MEIYAN JIANG: Open Payments
NPI 1952175481 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $68 |
| Janssen Biotech, Inc. | 2 | $54 |
| Geron Corporation | 2 | $49 |
| Karyopharm Therapeutics Inc. | 2 | $48 |
| Incyte Corporation | 2 | $44 |
| SOBI, INC | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $22 |
Products named: TECVAYLI, RYTELO, XPOVIO, KEYTRUDA, WELIREG, Vonjo, JAKAFI, CABOMETYX.
Industry payments across TX — which companies pay providers there.
